Showing 1191-1200 of 3049 results for "".
Unplugged: Cutting-Edge Aesthetic Medicine
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/unplugged-cutting-edge-aesthetic-medicine/20142/Jeanine Downie, MD shares pearls from her presentation in the Unplugged session she co-chaired with José Montes, MD. She discusses some of the latest tightening devices for the face, neck, and body, including EmFace, Zaffiro, and Sofwave. Plus, she reviews topics presented by colleagues throughout tDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)DermWire TV: Adbry Approved; Syringoma Option; Confusion over Vaccines and Injectables
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-adbry-approved-syringoma-option-confusion-over-vaccines-and-injectables/20041/Adbry (tralokinumab) from Leo Pharma is the newest biologic approved for moderate to severe atopic dermatitis in adults and is the first IL-13 blocker approved in the US. Pulse Bioscience’s nano-pulse stimulation (NPS) technology shows potential for the treatment of syringoma in a feasibility studyHow Will You Pay for Taxes in Retirement
https://practicaldermatology.com/topics/practice-management/how-will-you-pay-for-taxes-in-retirement--hgsepipo/18365/OJM Group Director of Financial Advisors Michael Lewellen, CFP presents an effective hedging strategy that can help you build retirement wealth while reducing your tax burden during your retirement years. Click here to request or download a free copy of Wealth Protection Planning for DermatologistsJoel Schlessinger MD Discusses Personal Phones in the Office
https://practicaldermatology.com/topics/practice-management/joel-schlessinger-md-discusses-personal-phones-in-the-office-/19276/Dealing with personal phone use at work is an issue that almost every business must consider. While it is important that people are available in case of an emergency, this rule can often be abused. In this video, Joel Schlessinger MD offers his advice on dealing with this office issue. Dr. Joel STaking a More Holistic View of the Pathogenesis of Acne
https://practicaldermatology.com/topics/acne-rosacea/taking-more-holistic-view-pathogenesis-acne/26539/Taking a More Holistic View of the Pathogenesis of AcneUnleashing Revenue Growth:Harnessing Patient Data
https://practicaldermatology.com/topics/practice-management/unleashing-revenue-growth-harnessing-patient-data/26968/Unleashing Revenue Growth: Harnessing Patient DataExpanding Horizons in Skin Cancer Treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/expanding-horizons-in-skin-cancer-treatment/18704/In Part 2 of this episode of Derm Insider, Host Neal Bhatia asks Anisha Patel, MD and Anthony Rossi, MD about advances in skin cancer therapies. Dr. Rossi discusses how to decide on the best regimens for the type of tumor being treated, and the importance of chemoprevention. They also talk more abouConquer Burnout
https://practicaldermatology.com/topics/practice-management/conquer-burnout/18732/Recognizing the signs of burnout is the first step to conquering this epidemic among physicians. Leading dermatologists Brian Berman, MD, PhD and Neil Sadick, MD talk to host Neal Bhatia, MD about the latest research into physician burnout and the probable causes, from an increase in legislative issRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHOR